WFH 2012 | World Congress in Paris | 8.-12. Juli 2012

Der VFTH e.V. präsentiert Forschungsergebnisse gewonnen aus Daten erfasst mit smart medication:

WFH 2012

smart medication – a new telemetric smartphone application for monitoring and evaluation of hemophilia home treatment. Hemophilia A and B are rare diseases and require medical care in specialized treatment centers. Because of long distances between patients and hemophilia center, telemedicine may be helpful to bring the right patient to the right doctor. Bleeding or treatment problems, usually reported during consultation at the hemophilia center, may be identified earlier and close to when they occur. Automated documentation and online analysis of the data is less time consuming and helps to avoid documentation errors.
W. MONDORF, H. POLLMANN, B. SIEGMUND, D. SCHMOLDT and A. RÖSCH; Haemostas, Frankfurt; ITH–Institut für Thrombophilie und Hämostaseologie, Münster; Philipps-Universität, Marburg, Germany. (Poster Num.: PO-MO-01)

gth-logo